<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta content="text/html;charset=utf-8" http-equiv="Content-Type"/>
    <title>CH.FHIR.IG.CH-VACD\SwissRisksForImmunizations - FHIR v4.0.1</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link href="fhir.css" rel="stylesheet"/>

    <!-- Bootstrap core CSS -->
    <link href="assets/css/bootstrap.css" rel="stylesheet"/>
    <link href="assets/css/bootstrap-fhir.css" rel="stylesheet"/>

    <!-- Project extras -->
    <link href="assets/css/project.css" rel="stylesheet"/>
    <link href="assets/css/pygments-manni.css" rel="stylesheet"/>
    <link href="assets/css/jquery-ui.css" rel="stylesheet"/>
  	<link href="assets/css/prism.css" rel="stylesheet" />
    <!-- Placeholder for child template CSS declarations -->
    <link href="assets/css/hl7.css" rel="stylesheet"/>
    <link href="assets/css/fhir.css" rel="stylesheet"/>

    <script type="text/javascript" src="fhir-table-scripts.js"> </script>

    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif]-->

    <!-- Favicons -->
    <link rel="apple-touch-icon-precomposed" sizes="144x144" href="assets/ico/apple-touch-icon-144-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="114x114" href="assets/ico/apple-touch-icon-114-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="72x72" href="assets/ico/apple-touch-icon-72-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-57-precomposed.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>

    <style type="text/css">h2{--heading-prefix:"10.35"}
    h3,h4,h5,h6{--heading-prefix:"10.35"}</style>
    <div id="segment-header" class="segment">  <!-- segment-header -->
      <div class="container">  <!-- container -->
        <!-- Placeholder for child template header declarations -->

            <!--
<div id="family-nav">
	<a id="logo" no-external="true" href="http://hl7.org/fhir"> <img
		alt="logo fhir" src="assets/images/fhir-logo-www.png" />
	</a>
</div>
-->


            <div id="hl7-nav">
    <a id="e-health-suisse-logo" no-external="true" href="https://www.e-health-suisse.ch/startseite.html">
        <img alt="visit the e-health-suisse website" height="60" src="assets/images/LogoDE_ehealthsuisse.svg" />
    </a>      
</div>

        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">CH VACD (R4)</span><br/>0.1.0 - STU 1 Informative Ballot</p>
        </div>
      </div> <!-- /container -->
    </div>  <!-- /segment-header -->

    <div id="segment-navbar" class="segment">  <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">  <!-- container -->
        <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
          <!--status-bar-->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" class="navbar-toggle" data-toggle="collapse" type="button">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a class="navbar-brand hidden" href="http://hl7.org/fhir/R4/index.html">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
              <ul xmlns="http://www.w3.org/1999/xhtml" class="nav navbar-nav">
  <!--<li><a href="toc.html">Table of Contents</a></li>-->
  <li><a href="index.html">Home</a></li>
  <li><a href="profiles.html">Profiles</a></li>
  <li><a href="extensions.html">Extensions</a></li>
  <li><a href="terminology.html">Terminology</a></li>
  <li><a href="artifacts.html">Artifacts</a></li>
</ul>
            </div>  <!-- /.nav-collapse -->
          </div>  <!-- /.container -->
        </nav>  <!-- /.navbar -->
      <!-- /HEADER CONTENT -->
      </div>  <!-- /container -->
    </div>  <!-- /segment-navbar -->
    <!--status-bar-->
    <div id="segment-breadcrumb" class="segment">  <!-- segment-breadcrumb -->
      <div class="container">  <!-- container -->
        <ul class="breadcrumb">
          <li><a href='toc.html'><b>Table of Contents</b></a></li><li><a href='artifacts.html'><b>Artifacts Summary</b></a></li><li><b>SwissRisksForImmunizations</b></li>
        </ul>
      </div>  <!-- /container -->
    </div>  <!-- /segment-breadcrumb -->

    <div id="segment-content">  <!-- segment-content -->
      <div class="container">  <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<div class="col-12">
  <!--ReleaseHeader--><p id="publish-box">This page is part of the CH VACD (R4) (v0.1.0: <a data-no-external="true" href="https://confluence.hl7.org/display/HL7/HL7+Balloting" title="Standard for Trial-Use">STU</a> 1) based on <a data-no-external="true" href="http://hl7.org/fhir/R4">FHIR (HL7® FHIR® Standard) R4</a>. The current version which supersedes this version is <a data-no-external="true" href="http://fhir.ch/ig/ch-vacd">6.0.0</a>.  For a full list of available versions, see the <a data-no-external="true" href="http://fhir.ch/ig/ch-vacd/history.html">Directory of published versions</a></p><!--EndReleaseHeader-->
  






<ul class="nav nav-tabs">

  <li class="active">
    <a href="#">Narrative Content</a>
  </li>


  
    <li>
      <a href="ValueSet-ch-vacd-risks-vs.xml.html">XML</a>
    </li>
  


  
    <li>
      <a href="ValueSet-ch-vacd-risks-vs.json.html">JSON</a>
    </li>
  


  
    <li>
      <a href="ValueSet-ch-vacd-risks-vs.ttl.html">TTL</a>
    </li>
  



</ul>

  <a name="root"> </a>
  <h2 id="root">ValueSet: SwissRisksForImmunizations</h2>
  <p>
    <b>Summary</b>
  </p>
  <table class="grid">
<tbody>
<tr><td>Defining URL:</td><td>http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-vs</td></tr>
 <tr><td>Version:</td><td>0.1.0</td></tr>
 <tr><td>Name:</td><td>SwissRisksForImmunizations</td></tr>
 <tr><td>Status:</td><td>Active as of 2021-02-12T16:53:02+01:00</td></tr>
 <tr><td>Definition:</td><td><p>The medical and exposision risks used in Switzerland.</p>
</td></tr>
 <tr><td>Publisher:</td><td>eHealth Suisse</td></tr>
 <tr><td>Copyright:</td><td><p>CC-BY-SA-4.0</p>
</td></tr>
 <tr><td>Source Resource:</td><td><a href="ValueSet-ch-vacd-risks-vs.xml.html">XML</a> / <a href="ValueSet-ch-vacd-risks-vs.json.html">JSON</a> / <a href="ValueSet-ch-vacd-risks-vs.ttl.html">Turtle</a></td></tr>
</tbody></table>


  <p>
    <b>References</b>
  </p>
  
<ul>
 <li><a href="StructureDefinition-ch-vacd-recommendation-section-medical-problems.html">CH VACD Recommendation Medical Problems Section Profile</a></li>
 <li><a href="StructureDefinition-ch-vacd-section-medical-problems.html">CH VACD Medical Problems Section Profile</a></li>
</ul>


  <!-- insert intro if present -->
  



  <a name="definition"> </a>

<!-- Content Logical Definition heading in the fragment -->
  <h3>Logical Definition (CLD)</h3>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href="CodeSystem-ch-vacd-complication-risks-cs.html"><code>urn:oid:2.16.756.5.30.1.127.3.3.1</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Deutsch (Schweiz) (German (Switzerland), de)</b></td><td><b>French (Switzerland) (fr)</b></td><td><b>Italian (Switzerland) (it)</b></td><td><b>English (United States) (English (United States), en)</b></td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113001">113001</a></td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114036">114036</a></td><td>ANDERE_LEBERERKRANKUNG</td><td>ANDERE_LEBERERKRANKUNG</td><td>ANDERE_LEBERERKRANKUNG</td><td>ANDERE_LEBERERKRANKUNG</td><td>ANDERE_LEBERERKRANKUNG</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114006">114006</a></td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114033">114033</a></td><td>ANDERE_NIERENERKRANKUNG</td><td>ANDERE_NIERENERKRANKUNG</td><td>ANDERE_NIERENERKRANKUNG</td><td>ANDERE_NIERENERKRANKUNG</td><td>ANDERE_NIERENERKRANKUNG</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114034">114034</a></td><td>ANDERER_KREBS</td><td>ANDERER_KREBS</td><td>ANDERER_KREBS</td><td>ANDERER_KREBS</td><td>ANDERER_KREBS</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114025">114025</a></td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114021">114021</a></td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114005">114005</a></td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114003">114003</a></td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114007">114007</a></td><td>CHRONISCHE_LEBERERKRANKUNG</td><td>CHRONISCHE_LEBERERKRANKUNG</td><td>CHRONISCHE_LEBERERKRANKUNG</td><td>CHRONISCHE_LEBERERKRANKUNG</td><td>CHRONISCHE_LEBERERKRANKUNG</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113002">113002</a></td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114015">114015</a></td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114019">114019</a></td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114020">114020</a></td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113004">113004</a></td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114037">114037</a></td><td>HAEMODIALYSEPATIENT</td><td>HAEMODIALYSEPATIENT</td><td>HAEMODIALYSEPATIENT</td><td>HAEMODIALYSEPATIENT</td><td>HAEMODIALYSEPATIENT</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114038">114038</a></td><td>HAEMOPHILIE_PATIENT</td><td>HAEMOPHILIE_PATIENT</td><td>HAEMOPHILIE_PATIENT</td><td>HAEMOPHILIE_PATIENT</td><td>HAEMOPHILIE_PATIENT</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114001">114001</a></td><td>HERZINSUFFIZIENZ</td><td>HERZINSUFFIZIENZ</td><td>HERZINSUFFIZIENZ</td><td>HERZINSUFFIZIENZ</td><td>HERZINSUFFIZIENZ</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113007">113007</a></td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113008">113008</a></td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113009">113009</a></td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114018">114018</a></td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114002">114002</a></td><td>KARDIOPATHIE</td><td>KARDIOPATHIE</td><td>KARDIOPATHIE</td><td>KARDIOPATHIE</td><td>KARDIOPATHIE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114008">114008</a></td><td>LEBERZIRRHOSE</td><td>LEBERZIRRHOSE</td><td>LEBERZIRRHOSE</td><td>LEBERZIRRHOSE</td><td>LEBERZIRRHOSE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113012">113012</a></td><td>LYMPHOM_LEUKAEMIE_MYELOM</td><td>LYMPHOM_LEUKAEMIE_MYELOM</td><td>LYMPHOM_LEUKAEMIE_MYELOM</td><td>LYMPHOM_LEUKAEMIE_MYELOM</td><td>LYMPHOM_LEUKAEMIE_MYELOM</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-118001">118001</a></td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113014">113014</a></td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114026">114026</a></td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114022">114022</a></td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114016">114016</a></td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113018">113018</a></td><td>NEPHROTISCHES_SYNDROM</td><td>NEPHROTISCHES_SYNDROM</td><td>NEPHROTISCHES_SYNDROM</td><td>NEPHROTISCHES_SYNDROM</td><td>NEPHROTISCHES_SYNDROM</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114012">114012</a></td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113023">113023</a></td><td>NIERENINSUFFIZIENZ</td><td>NIERENINSUFFIZIENZ</td><td>NIERENINSUFFIZIENZ</td><td>NIERENINSUFFIZIENZ</td><td>NIERENINSUFFIZIENZ</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114035">114035</a></td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113035">113035</a></td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114032">114032</a></td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114028">114028</a></td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113021">113021</a></td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114004">114004</a></td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114014">114014</a></td><td>SICHELZELLANAEMIE</td><td>SICHELZELLANAEMIE</td><td>SICHELZELLANAEMIE</td><td>SICHELZELLANAEMIE</td><td>SICHELZELLANAEMIE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113036">113036</a></td><td>ZOELIAKIE</td><td>ZOELIAKIE</td><td>ZOELIAKIE</td><td>ZOELIAKIE</td><td>ZOELIAKIE</td></tr></table></li><li>Include these codes as defined in <a href="CodeSystem-ch-vacd-exposure-risks-cs.html"><code>urn:oid:2.16.756.5.30.1.127.3.3.2</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Deutsch (Schweiz) (German (Switzerland), de)</b></td><td><b>French (Switzerland) (fr)</b></td><td><b>Italian (Switzerland) (it)</b></td><td><b>English (United States) (English (United States), en)</b></td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213001">213001</a></td><td>BESCHAEFTIGTE_IM_GESUNDHEITSWESEN</td><td>BESCHAEFTIGTE_IM_GESUNDHEITSWESEN</td><td>BESCHAEFTIGTE_IM_GESUNDHEITSWESEN</td><td>BESCHAEFTIGTE_IM_GESUNDHEITSWESEN</td><td>BESCHAEFTIGTE_IM_GESUNDHEITSWESEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213028">213028</a></td><td>ENGE_KONTAKTPERSONEN_VON_MENINGOKOKKEN_ERKRANKTEN</td><td>ENGE_KONTAKTPERSONEN_VON_MENINGOKOKKEN_ERKRANKTEN</td><td>ENGE_KONTAKTPERSONEN_VON_MENINGOKOKKEN_ERKRANKTEN</td><td>ENGE_KONTAKTPERSONEN_VON_MENINGOKOKKEN_ERKRANKTEN</td><td>ENGE_KONTAKTPERSONEN_VON_MENINGOKOKKEN_ERKRANKTEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213003">213003</a></td><td>ERWACHSENE_UND_KINDER_AB_6_JAHREN_DIE_IN_ENDEMIEGEBIET_WOHNEN_ODER_SICH_TEILWEISE_DORT_AUFHALTEN</td><td>ERWACHSENE_UND_KINDER_AB_6_JAHREN_DIE_IN_ENDEMIEGEBIET_WOHNEN_ODER_SICH_TEILWEISE_DORT_AUFHALTEN</td><td>ERWACHSENE_UND_KINDER_AB_6_JAHREN_DIE_IN_ENDEMIEGEBIET_WOHNEN_ODER_SICH_TEILWEISE_DORT_AUFHALTEN</td><td>ERWACHSENE_UND_KINDER_AB_6_JAHREN_DIE_IN_ENDEMIEGEBIET_WOHNEN_ODER_SICH_TEILWEISE_DORT_AUFHALTEN</td><td>ERWACHSENE_UND_KINDER_AB_6_JAHREN_DIE_IN_ENDEMIEGEBIET_WOHNEN_ODER_SICH_TEILWEISE_DORT_AUFHALTEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213005">213005</a></td><td>FAMILIENANGEHOERIGE_VON_PERSONEN_MIT_EINEM_ERHOEHTEN_RISIKO</td><td>FAMILIENANGEHOERIGE_VON_PERSONEN_MIT_EINEM_ERHOEHTEN_RISIKO</td><td>FAMILIENANGEHOERIGE_VON_PERSONEN_MIT_EINEM_ERHOEHTEN_RISIKO</td><td>FAMILIENANGEHOERIGE_VON_PERSONEN_MIT_EINEM_ERHOEHTEN_RISIKO</td><td>FAMILIENANGEHOERIGE_VON_PERSONEN_MIT_EINEM_ERHOEHTEN_RISIKO</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213006">213006</a></td><td>FLEDERMAUSFORSCHER_UND_SCHUETZER</td><td>FLEDERMAUSFORSCHER_UND_SCHUETZER</td><td>FLEDERMAUSFORSCHER_UND_SCHUETZER</td><td>FLEDERMAUSFORSCHER_UND_SCHUETZER</td><td>FLEDERMAUSFORSCHER_UND_SCHUETZER</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213007">213007</a></td><td>GEISTIG_BEHINDERTE_PERSONEN_IN_HEIMEN_UND_DEREN_BETREUERINNEN</td><td>GEISTIG_BEHINDERTE_PERSONEN_IN_HEIMEN_UND_DEREN_BETREUERINNEN</td><td>GEISTIG_BEHINDERTE_PERSONEN_IN_HEIMEN_UND_DEREN_BETREUERINNEN</td><td>GEISTIG_BEHINDERTE_PERSONEN_IN_HEIMEN_UND_DEREN_BETREUERINNEN</td><td>GEISTIG_BEHINDERTE_PERSONEN_IN_HEIMEN_UND_DEREN_BETREUERINNEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213010">213010</a></td><td>KANALISATIONSARBEITER_UND_ANGESTELLTE_VON_KLAERANLAGEN</td><td>KANALISATIONSARBEITER_UND_ANGESTELLTE_VON_KLAERANLAGEN</td><td>KANALISATIONSARBEITER_UND_ANGESTELLTE_VON_KLAERANLAGEN</td><td>KANALISATIONSARBEITER_UND_ANGESTELLTE_VON_KLAERANLAGEN</td><td>KANALISATIONSARBEITER_UND_ANGESTELLTE_VON_KLAERANLAGEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213011">213011</a></td><td>KINDER_AUS_LAENDERN_MIT_MITTLERER_UND_HOHER_ENDEMIZITAET_DIE_IN_DER_SCHWEIZ_LEBEN_UND_FUER_EINEN_VORUEBERGEHENDEN_AUFENTHALT_IN_IHR_HERKUNFTSLAND_ZURUECKKEHREN</td><td>KINDER_AUS_LAENDERN_MIT_MITTLERER_UND_HOHER_ENDEMIZITAET_DIE_IN_DER_SCHWEIZ_LEBEN_UND_FUER_EINEN_VORUEBERGEHENDEN_AUFENTHALT_IN_IHR_HERKUNFTSLAND_ZURUECKKEHREN</td><td>KINDER_AUS_LAENDERN_MIT_MITTLERER_UND_HOHER_ENDEMIZITAET_DIE_IN_DER_SCHWEIZ_LEBEN_UND_FUER_EINEN_VORUEBERGEHENDEN_AUFENTHALT_IN_IHR_HERKUNFTSLAND_ZURUECKKEHREN</td><td>KINDER_AUS_LAENDERN_MIT_MITTLERER_UND_HOHER_ENDEMIZITAET_DIE_IN_DER_SCHWEIZ_LEBEN_UND_FUER_EINEN_VORUEBERGEHENDEN_AUFENTHALT_IN_IHR_HERKUNFTSLAND_ZURUECKKEHREN</td><td>KINDER_AUS_LAENDERN_MIT_MITTLERER_UND_HOHER_ENDEMIZITAET_DIE_IN_DER_SCHWEIZ_LEBEN_UND_FUER_EINEN_VORUEBERGEHENDEN_AUFENTHALT_IN_IHR_HERKUNFTSLAND_ZURUECKKEHREN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213031">213031</a></td><td>KINDERKRIPPE_HORT_VOR_5_MONATEN</td><td>KINDERKRIPPE_HORT_VOR_5_MONATEN</td><td>KINDERKRIPPE_HORT_VOR_5_MONATEN</td><td>KINDERKRIPPE_HORT_VOR_5_MONATEN</td><td>KINDERKRIPPE_HORT_VOR_5_MONATEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213012">213012</a></td><td>KONSUMENTEN_VON_INJIZIERBAREN_DROGEN_UND_DEREN_KONTAKTPERSONEN</td><td>KONSUMENTEN_VON_INJIZIERBAREN_DROGEN_UND_DEREN_KONTAKTPERSONEN</td><td>KONSUMENTEN_VON_INJIZIERBAREN_DROGEN_UND_DEREN_KONTAKTPERSONEN</td><td>KONSUMENTEN_VON_INJIZIERBAREN_DROGEN_UND_DEREN_KONTAKTPERSONEN</td><td>KONSUMENTEN_VON_INJIZIERBAREN_DROGEN_UND_DEREN_KONTAKTPERSONEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213032">213032</a></td><td>KONTAKTPERSONEN_VON_EINER_SCHWANGEREN_FRAU</td><td>KONTAKTPERSONEN_VON_EINER_SCHWANGEREN_FRAU</td><td>KONTAKTPERSONEN_VON_EINER_SCHWANGEREN_FRAU</td><td>KONTAKTPERSONEN_VON_EINER_SCHWANGEREN_FRAU</td><td>KONTAKTPERSONEN_VON_EINER_SCHWANGEREN_FRAU</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213027">213027</a></td><td>KONTAKTPERSONEN_VON_HEPATITIS_A_ERKRANKTEN</td><td>KONTAKTPERSONEN_VON_HEPATITIS_A_ERKRANKTEN</td><td>KONTAKTPERSONEN_VON_HEPATITIS_A_ERKRANKTEN</td><td>KONTAKTPERSONEN_VON_HEPATITIS_A_ERKRANKTEN</td><td>KONTAKTPERSONEN_VON_HEPATITIS_A_ERKRANKTEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213026">213026</a></td><td>KONTAKTPERSONEN_VON_HEPATITIS_B_ERKRANKTEN</td><td>KONTAKTPERSONEN_VON_HEPATITIS_B_ERKRANKTEN</td><td>KONTAKTPERSONEN_VON_HEPATITIS_B_ERKRANKTEN</td><td>KONTAKTPERSONEN_VON_HEPATITIS_B_ERKRANKTEN</td><td>KONTAKTPERSONEN_VON_HEPATITIS_B_ERKRANKTEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213030">213030</a></td><td>LABORPERSONAL_MIT_BAKTERIEN_EXPOSITIONSRISIKO</td><td>LABORPERSONAL_MIT_BAKTERIEN_EXPOSITIONSRISIKO</td><td>LABORPERSONAL_MIT_BAKTERIEN_EXPOSITIONSRISIKO</td><td>LABORPERSONAL_MIT_BAKTERIEN_EXPOSITIONSRISIKO</td><td>LABORPERSONAL_MIT_BAKTERIEN_EXPOSITIONSRISIKO</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213029">213029</a></td><td>LABORPERSONAL_MIT_VIRUS_EXPOSITIONSRISIKO</td><td>LABORPERSONAL_MIT_VIRUS_EXPOSITIONSRISIKO</td><td>LABORPERSONAL_MIT_VIRUS_EXPOSITIONSRISIKO</td><td>LABORPERSONAL_MIT_VIRUS_EXPOSITIONSRISIKO</td><td>LABORPERSONAL_MIT_VIRUS_EXPOSITIONSRISIKO</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213014">213014</a></td><td>MAENNER_DIE_MIT_MAENNERN_GESCHLECHTSVERKEHR_HABEN</td><td>MAENNER_DIE_MIT_MAENNERN_GESCHLECHTSVERKEHR_HABEN</td><td>MAENNER_DIE_MIT_MAENNERN_GESCHLECHTSVERKEHR_HABEN</td><td>MAENNER_DIE_MIT_MAENNERN_GESCHLECHTSVERKEHR_HABEN</td><td>MAENNER_DIE_MIT_MAENNERN_GESCHLECHTSVERKEHR_HABEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213033">213033</a></td><td>MITARBEITENDE_VON_KINDERKRIPPEN</td><td>MITARBEITENDE_VON_KINDERKRIPPEN</td><td>MITARBEITENDE_VON_KINDERKRIPPEN</td><td>MITARBEITENDE_VON_KINDERKRIPPEN</td><td>MITARBEITENDE_VON_KINDERKRIPPEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213024">213024</a></td><td>NEUGEBORENE_UND_SAEUGLINGE_UNTER_12_MONATEN_AUS_LAENDERN_MIT_HOHER_TUBERKULOSE_PRAEVALENZ_DIE_WAHRSCHEINLICH_WIEDER_DORTHIN_ZURUECKKEHREN_IN_IHREM_ERSTEN_LEBENSJAHR</td><td>NEUGEBORENE_UND_SAEUGLINGE_UNTER_12_MONATEN_AUS_LAENDERN_MIT_HOHER_TUBERKULOSE_PRAEVALENZ_DIE_WAHRSCHEINLICH_WIEDER_DORTHIN_ZURUECKKEHREN_IN_IHREM_ERSTEN_LEBENSJAHR</td><td>NEUGEBORENE_UND_SAEUGLINGE_UNTER_12_MONATEN_AUS_LAENDERN_MIT_HOHER_TUBERKULOSE_PRAEVALENZ_DIE_WAHRSCHEINLICH_WIEDER_DORTHIN_ZURUECKKEHREN_IN_IHREM_ERSTEN_LEBENSJAHR</td><td>NEUGEBORENE_UND_SAEUGLINGE_UNTER_12_MONATEN_AUS_LAENDERN_MIT_HOHER_TUBERKULOSE_PRAEVALENZ_DIE_WAHRSCHEINLICH_WIEDER_DORTHIN_ZURUECKKEHREN_IN_IHREM_ERSTEN_LEBENSJAHR</td><td>NEUGEBORENE_UND_SAEUGLINGE_UNTER_12_MONATEN_AUS_LAENDERN_MIT_HOHER_TUBERKULOSE_PRAEVALENZ_DIE_WAHRSCHEINLICH_WIEDER_DORTHIN_ZURUECKKEHREN_IN_IHREM_ERSTEN_LEBENSJAHR</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213025">213025</a></td><td>NEUGEBORENE_VON_HBSAG_POSITIVEN_MUETTERN</td><td>NEUGEBORENE_VON_HBSAG_POSITIVEN_MUETTERN</td><td>NEUGEBORENE_VON_HBSAG_POSITIVEN_MUETTERN</td><td>NEUGEBORENE_VON_HBSAG_POSITIVEN_MUETTERN</td><td>NEUGEBORENE_VON_HBSAG_POSITIVEN_MUETTERN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213015">213015</a></td><td>PATIENTINNEN_UND_PATIENTEN_IN_PFLEGEHEIMEN_UND_IN_EINRICHTUNGEN_FUER_PERSONEN_MIT_CHRONISCHEN_ERKRANKUNGEN</td><td>PATIENTINNEN_UND_PATIENTEN_IN_PFLEGEHEIMEN_UND_IN_EINRICHTUNGEN_FUER_PERSONEN_MIT_CHRONISCHEN_ERKRANKUNGEN</td><td>PATIENTINNEN_UND_PATIENTEN_IN_PFLEGEHEIMEN_UND_IN_EINRICHTUNGEN_FUER_PERSONEN_MIT_CHRONISCHEN_ERKRANKUNGEN</td><td>PATIENTINNEN_UND_PATIENTEN_IN_PFLEGEHEIMEN_UND_IN_EINRICHTUNGEN_FUER_PERSONEN_MIT_CHRONISCHEN_ERKRANKUNGEN</td><td>PATIENTINNEN_UND_PATIENTEN_IN_PFLEGEHEIMEN_UND_IN_EINRICHTUNGEN_FUER_PERSONEN_MIT_CHRONISCHEN_ERKRANKUNGEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213016">213016</a></td><td>PERSONEN_AUS_LAENDERN_MIT_HOHER_ODER_INTERMEDIAERER_HEPATITIS_B_ENDEMIZITAET</td><td>PERSONEN_AUS_LAENDERN_MIT_HOHER_ODER_INTERMEDIAERER_HEPATITIS_B_ENDEMIZITAET</td><td>PERSONEN_AUS_LAENDERN_MIT_HOHER_ODER_INTERMEDIAERER_HEPATITIS_B_ENDEMIZITAET</td><td>PERSONEN_AUS_LAENDERN_MIT_HOHER_ODER_INTERMEDIAERER_HEPATITIS_B_ENDEMIZITAET</td><td>PERSONEN_AUS_LAENDERN_MIT_HOHER_ODER_INTERMEDIAERER_HEPATITIS_B_ENDEMIZITAET</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213017">213017</a></td><td>PERSONEN_MIT_EINER_SEXUELL_UEBERTRAGBAREN_KRANKHEIT</td><td>PERSONEN_MIT_EINER_SEXUELL_UEBERTRAGBAREN_KRANKHEIT</td><td>PERSONEN_MIT_EINER_SEXUELL_UEBERTRAGBAREN_KRANKHEIT</td><td>PERSONEN_MIT_EINER_SEXUELL_UEBERTRAGBAREN_KRANKHEIT</td><td>PERSONEN_MIT_EINER_SEXUELL_UEBERTRAGBAREN_KRANKHEIT</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213018">213018</a></td><td>PERSONEN_MIT_ENGEM_KONTAKT_ZU_PERSONEN_AUS_LAENDERN_MIT_HOHER_ENDEMIZITAET</td><td>PERSONEN_MIT_ENGEM_KONTAKT_ZU_PERSONEN_AUS_LAENDERN_MIT_HOHER_ENDEMIZITAET</td><td>PERSONEN_MIT_ENGEM_KONTAKT_ZU_PERSONEN_AUS_LAENDERN_MIT_HOHER_ENDEMIZITAET</td><td>PERSONEN_MIT_ENGEM_KONTAKT_ZU_PERSONEN_AUS_LAENDERN_MIT_HOHER_ENDEMIZITAET</td><td>PERSONEN_MIT_ENGEM_KONTAKT_ZU_PERSONEN_AUS_LAENDERN_MIT_HOHER_ENDEMIZITAET</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213019">213019</a></td><td>PERSONEN_MIT_HAEUFIG_WECHSELNDEN_SEXUALPARTNERN</td><td>PERSONEN_MIT_HAEUFIG_WECHSELNDEN_SEXUALPARTNERN</td><td>PERSONEN_MIT_HAEUFIG_WECHSELNDEN_SEXUALPARTNERN</td><td>PERSONEN_MIT_HAEUFIG_WECHSELNDEN_SEXUALPARTNERN</td><td>PERSONEN_MIT_HAEUFIG_WECHSELNDEN_SEXUALPARTNERN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213020">213020</a></td><td>PERSONEN_MIT_REGELMAESSIGEM_KONTAKT_BERUFLICH_ODER_FAMILIAER_ZU_SAEUGLINGEN_UNTER_6_MONATEN_ODER_SCHWANGERE_FRAUEN</td><td>PERSONEN_MIT_REGELMAESSIGEM_KONTAKT_BERUFLICH_ODER_FAMILIAER_ZU_SAEUGLINGEN_UNTER_6_MONATEN_ODER_SCHWANGERE_FRAUEN</td><td>PERSONEN_MIT_REGELMAESSIGEM_KONTAKT_BERUFLICH_ODER_FAMILIAER_ZU_SAEUGLINGEN_UNTER_6_MONATEN_ODER_SCHWANGERE_FRAUEN</td><td>PERSONEN_MIT_REGELMAESSIGEM_KONTAKT_BERUFLICH_ODER_FAMILIAER_ZU_SAEUGLINGEN_UNTER_6_MONATEN_ODER_SCHWANGERE_FRAUEN</td><td>PERSONEN_MIT_REGELMAESSIGEM_KONTAKT_BERUFLICH_ODER_FAMILIAER_ZU_SAEUGLINGEN_UNTER_6_MONATEN_ODER_SCHWANGERE_FRAUEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213021">213021</a></td><td>REKRUTEN_MILITAER</td><td>REKRUTEN_MILITAER</td><td>REKRUTEN_MILITAER</td><td>REKRUTEN_MILITAER</td><td>REKRUTEN_MILITAER</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213022">213022</a></td><td>SOZIALARBEITER_GEFAENGNISPERSONAL_UND_POLIZEIANGESTELLTE_MIT_HAEUFIGEM_KONTAKT_ZU_KONSUMENTEN_VON_INJIZIERBAREN_DROGEN</td><td>SOZIALARBEITER_GEFAENGNISPERSONAL_UND_POLIZEIANGESTELLTE_MIT_HAEUFIGEM_KONTAKT_ZU_KONSUMENTEN_VON_INJIZIERBAREN_DROGEN</td><td>SOZIALARBEITER_GEFAENGNISPERSONAL_UND_POLIZEIANGESTELLTE_MIT_HAEUFIGEM_KONTAKT_ZU_KONSUMENTEN_VON_INJIZIERBAREN_DROGEN</td><td>SOZIALARBEITER_GEFAENGNISPERSONAL_UND_POLIZEIANGESTELLTE_MIT_HAEUFIGEM_KONTAKT_ZU_KONSUMENTEN_VON_INJIZIERBAREN_DROGEN</td><td>SOZIALARBEITER_GEFAENGNISPERSONAL_UND_POLIZEIANGESTELLTE_MIT_HAEUFIGEM_KONTAKT_ZU_KONSUMENTEN_VON_INJIZIERBAREN_DROGEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213023">213023</a></td><td>TIERAERZTE_INKL_STUDENTEN_PRAXISANGESTELLTE</td><td>TIERAERZTE_INKL_STUDENTEN_PRAXISANGESTELLTE</td><td>TIERAERZTE_INKL_STUDENTEN_PRAXISANGESTELLTE</td><td>TIERAERZTE_INKL_STUDENTEN_PRAXISANGESTELLTE</td><td>TIERAERZTE_INKL_STUDENTEN_PRAXISANGESTELLTE</td></tr></table></li></ul></div>

  <p>&#160;</p>
  <a name="expansion"> </a>
  <h3 id="expansion">Expansion</h3>

  <div xmlns="http://www.w3.org/1999/xhtml"><p>This value set contains 69 concepts</p><div style="border: black 1px dotted; background-color: #EEEEEE; padding: 8px; margin-bottom: 8px"><p>Expansion based on: </p><ul><li><a href="CodeSystem-ch-vacd-exposure-risks-cs.html">Swiss Exposure Risks Codesystem v0.1.0 (CodeSystem)</a></li><li><a href="CodeSystem-ch-vacd-complication-risks-cs.html">Swiss Complication Risks Codesystem v0.1.0 (CodeSystem)</a></li></ul></div><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>System</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113001"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113001">113001</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114036"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114036">114036</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ANDERE_LEBERERKRANKUNG</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114006"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114006">114006</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114033"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114033">114033</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ANDERE_NIERENERKRANKUNG</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114034"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114034">114034</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ANDERER_KREBS</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114025"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114025">114025</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114021"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114021">114021</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114005"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114005">114005</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114003"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114003">114003</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114007"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114007">114007</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>CHRONISCHE_LEBERERKRANKUNG</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113002"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113002">113002</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114015"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114015">114015</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114019"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114019">114019</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114020"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114020">114020</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113004"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113004">113004</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114037"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114037">114037</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>HAEMODIALYSEPATIENT</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114038"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114038">114038</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>HAEMOPHILIE_PATIENT</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114001"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114001">114001</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>HERZINSUFFIZIENZ</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113007"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113007">113007</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113008"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113008">113008</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113009"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113009">113009</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114018"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114018">114018</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114002"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114002">114002</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>KARDIOPATHIE</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114008"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114008">114008</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>LEBERZIRRHOSE</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113012"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113012">113012</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>LYMPHOM_LEUKAEMIE_MYELOM</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-118001"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-118001">118001</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113014"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113014">113014</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114026"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114026">114026</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114022"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114022">114022</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114016"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114016">114016</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113018"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113018">113018</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>NEPHROTISCHES_SYNDROM</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114012"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114012">114012</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113023"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113023">113023</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>NIERENINSUFFIZIENZ</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114035"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114035">114035</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113035"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113035">113035</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114032"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114032">114032</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114028"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114028">114028</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113021"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113021">113021</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114004"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114004">114004</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114014"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114014">114014</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>SICHELZELLANAEMIE</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113036"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113036">113036</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ZOELIAKIE</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213001"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213001">213001</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>BESCHAEFTIGTE_IM_GESUNDHEITSWESEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213028"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213028">213028</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>ENGE_KONTAKTPERSONEN_VON_MENINGOKOKKEN_ERKRANKTEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213003"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213003">213003</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>ERWACHSENE_UND_KINDER_AB_6_JAHREN_DIE_IN_ENDEMIEGEBIET_WOHNEN_ODER_SICH_TEILWEISE_DORT_AUFHALTEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213005"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213005">213005</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>FAMILIENANGEHOERIGE_VON_PERSONEN_MIT_EINEM_ERHOEHTEN_RISIKO</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213006"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213006">213006</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>FLEDERMAUSFORSCHER_UND_SCHUETZER</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213007"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213007">213007</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>GEISTIG_BEHINDERTE_PERSONEN_IN_HEIMEN_UND_DEREN_BETREUERINNEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213010"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213010">213010</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KANALISATIONSARBEITER_UND_ANGESTELLTE_VON_KLAERANLAGEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213011"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213011">213011</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KINDER_AUS_LAENDERN_MIT_MITTLERER_UND_HOHER_ENDEMIZITAET_DIE_IN_DER_SCHWEIZ_LEBEN_UND_FUER_EINEN_VORUEBERGEHENDEN_AUFENTHALT_IN_IHR_HERKUNFTSLAND_ZURUECKKEHREN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213031"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213031">213031</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KINDERKRIPPE_HORT_VOR_5_MONATEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213012"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213012">213012</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KONSUMENTEN_VON_INJIZIERBAREN_DROGEN_UND_DEREN_KONTAKTPERSONEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213032"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213032">213032</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KONTAKTPERSONEN_VON_EINER_SCHWANGEREN_FRAU</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213027"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213027">213027</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KONTAKTPERSONEN_VON_HEPATITIS_A_ERKRANKTEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213026"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213026">213026</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KONTAKTPERSONEN_VON_HEPATITIS_B_ERKRANKTEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213030"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213030">213030</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>LABORPERSONAL_MIT_BAKTERIEN_EXPOSITIONSRISIKO</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213029"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213029">213029</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>LABORPERSONAL_MIT_VIRUS_EXPOSITIONSRISIKO</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213014"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213014">213014</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>MAENNER_DIE_MIT_MAENNERN_GESCHLECHTSVERKEHR_HABEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213033"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213033">213033</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>MITARBEITENDE_VON_KINDERKRIPPEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213024"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213024">213024</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>NEUGEBORENE_UND_SAEUGLINGE_UNTER_12_MONATEN_AUS_LAENDERN_MIT_HOHER_TUBERKULOSE_PRAEVALENZ_DIE_WAHRSCHEINLICH_WIEDER_DORTHIN_ZURUECKKEHREN_IN_IHREM_ERSTEN_LEBENSJAHR</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213025"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213025">213025</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>NEUGEBORENE_VON_HBSAG_POSITIVEN_MUETTERN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213015"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213015">213015</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>PATIENTINNEN_UND_PATIENTEN_IN_PFLEGEHEIMEN_UND_IN_EINRICHTUNGEN_FUER_PERSONEN_MIT_CHRONISCHEN_ERKRANKUNGEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213016"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213016">213016</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>PERSONEN_AUS_LAENDERN_MIT_HOHER_ODER_INTERMEDIAERER_HEPATITIS_B_ENDEMIZITAET</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213017"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213017">213017</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>PERSONEN_MIT_EINER_SEXUELL_UEBERTRAGBAREN_KRANKHEIT</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213018"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213018">213018</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>PERSONEN_MIT_ENGEM_KONTAKT_ZU_PERSONEN_AUS_LAENDERN_MIT_HOHER_ENDEMIZITAET</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213019"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213019">213019</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>PERSONEN_MIT_HAEUFIG_WECHSELNDEN_SEXUALPARTNERN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213020"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213020">213020</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>PERSONEN_MIT_REGELMAESSIGEM_KONTAKT_BERUFLICH_ODER_FAMILIAER_ZU_SAEUGLINGEN_UNTER_6_MONATEN_ODER_SCHWANGERE_FRAUEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213021"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213021">213021</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>REKRUTEN_MILITAER</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213022"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213022">213022</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>SOZIALARBEITER_GEFAENGNISPERSONAL_UND_POLIZEIANGESTELLTE_MIT_HAEUFIGEM_KONTAKT_ZU_KONSUMENTEN_VON_INJIZIERBAREN_DROGEN</td><td/></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213023"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213023">213023</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>TIERAERZTE_INKL_STUDENTEN_PRAXISANGESTELLTE</td><td/></tr></table></div>

  <hr/>
  <p>
    Explanation of the columns that may appear on this page:
  </p>
  <table class="grid">
    <tr>
      <td>Level</td>
      <td>A few code lists that FHIR defines are hierarchical - each code is assigned a level.
          In this scheme, some codes are under other codes, and imply that the code they are under also applies</td>
    </tr>
    <tr>
      <td>Source</td>
      <td>The source of the definition of the code (when the value set draws in codes defined elsewhere)</td>
    </tr>
    <tr>
      <td>Code</td>
      <td>The code (used as the code in the resource instance)</td>
    </tr>
    <tr>
      <td>Display</td>
      <td>The display (used in the <i>display</i> element of a <a href="http://hl7.org/fhir/R4/datatypes.html#Coding">Coding</a>). If there is no display, implementers should not simply display the code, but map the concept into their application</td>
    </tr>
    <tr>
      <td>Definition</td>
      <td>An explanation of the meaning of the concept</td>
    </tr>
    <tr>
      <td>Comments</td>
      <td>Additional notes about how to use the code</td>
    </tr>
  </table>

  <!-- insert notes if present -->
  



  

</div>
        </div>  <!-- /inner-wrapper -->
      </div>  <!-- /row -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-content -->

  <script type="text/javascript" src="assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script type="text/javascript" src="assets/js/jquery-ui.min.js"> </script>

  <script type="text/javascript">
    $(document).ready(function(){
      if(window.location.hash != "") {
          $('a[href="' + window.location.hash + '"]').click()
      }
    });
  </script>
  <div id="segment-footer" igtool="footer" class="segment">  <!-- segment-footer -->
    <div class="container">  <!-- container -->
      <div class="inner-wrapper">
        <p>
          IG &#169; 2021+ <a style="color: #81BEF7" href="https://www.e-health-suisse.ch/startseite.html">eHealth Suisse</a>.  Package ch.fhir.ig.ch-vacd#0.1.0 based on <a style="color: #81BEF7" href="http://hl7.org/fhir/R4/">FHIR 4.0.1</a>. Generated <span title="Fri, Feb 12, 2021 16:53+0100">2021-02-12</span>
          <br/>
          <span style="color: #FFFF77">
                      Links: <a style="color: #81BEF7" href="toc.html">Table of Contents</a> |
                 <a style="color: #81BEF7" href="qa.html">QA Report</a>

| <a style="color: #81BEF7" target="_blank" href="https://docs.google.com/forms/d/e/1FAIpQLSejY5cinbQ4kHgGKMhncYu0mPuWb7euUkxfeXZeiUCFFa4k6g/viewform?usp=sf_link&amp;entry%2E1353807103=ch.fhir.ig.ch-vacd%230.1.0%20/ValueSet-ch-vacd-risks-vs.html&amp;entry%2E247644557=SwissRisksForImmunizations">Propose a change</a>

          </span>
        </p>
      </div>  <!-- /inner-wrapper -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-footer -->
  
  <div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
    <div class="container">  <!-- container -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-post-footer -->
  
  <!-- JS and analytics only. -->
  <!-- Bootstrap core JavaScript
  ================================================== -->
  <!-- Placed at the end of the document so the pages load faster -->
  <script type="text/javascript" src="assets/js/bootstrap.min.js"> </script>
  <script type="text/javascript" src="assets/js/respond.min.js"> </script>
  <script type="text/javascript" src="assets/js/anchor.min.js"> </script>
  <script>anchors.options.visible = 'hover'
anchors.add()</script>
  
  <!-- Analytics Below
  ================================================== -->
  </body>
</html>
